Amendment: SEC Form F-1/A filed by Haoxi Health Technology Limited
Unavailable
Unavailable
Save time and jump to the most important pieces.
6-K - Haoxi Health Technology Ltd (0001954594) (Filer)
6-K - Haoxi Health Technology Ltd (0001954594) (Filer)
6-K - Haoxi Health Technology Ltd (0001954594) (Filer)
BEIJING, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced that it has resolved to effect a reverse share split of the Company's ordinary shares, with the split ratio set at 1-for-25 (the "Reverse Share Split"). The Reverse Share Split was approved by the Company's shareholders at an annual general meeting of shareholders held on January 10, 2025. The Company's Class A ordinary shares will begin trading on an adjusted basis on the Nasdaq Capital Market, reflecting the Reverse Share Split, when the market opens on January 27, 2025, under the existing ticker symbol
BEIJING, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced the Company's wholly owned subsidiary Beijing Haoxi Digital Technology Co., Ltd. ("Beijing Haoxi") was awarded a Recharge Service Framework Contract (the "Contract") to provide comprehensive digital advertising services with a budget of RMB30 million for Tengyuan Media Advertising Co., Ltd. ("Tengyuan") and its clients. Pursuant to the Contract, Tengyuan has authorized Beijing Haoxi to produce customized internet marketing services through its network of media platforms that align with Tengyuan's unique
BEIJING, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced that the Company received a letter (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") on October 31, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure
Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced that against the backdrop of increasing global challenges, the Company is mobilizing its resources to actively fulfill its corporate social responsibility and is closely monitoring international humanitarian needs and collaborating with relevant organizations and groups to provide essential support for international medical aid. Amidst evolving global dynamics, numerous regions face pressing humanitarian needs. The Company, renowned for its expertise in digital marketing and commitment to social responsibility, is leveraging its capabilities to a